Crescent Biopharma, Inc.CBIONASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-68.76M
↓ 49% below average
Average (9y)
$-46.19M
Historical baseline
Range
High:$-12.78M
Low:$-68.76M
CAGR
+20.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-68.76M | -75.1% |
| 2023 | $-39.28M | +17.1% |
| 2022 | $-47.40M | +25.3% |
| 2021 | $-63.45M | -23.2% |
| 2020 | $-51.51M | +16.1% |
| 2019 | $-61.39M | -19.2% |
| 2018 | $-51.51M | -51.8% |
| 2017 | $-33.93M | -6.3% |
| 2016 | $-31.91M | -149.6% |
| 2015 | $-12.78M | - |